This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Laura Stoppel
Principal at RA Capital Management


Laura Stoppel is an Analyst on the Investment Team at RA Capital Management. Laura’s primary responsibility at RA Capital is to conduct due diligence on biotechnology companies. Prior to this role, Laura was a Senior Associate on the Oncology, Ophthalmology, and Neurology Teams within the TechAtlas division of RA Capital, where she mapped competitive landscapes of drugs and medical devices for disease indications and capabilities, with a focus on hematologic malignancies, cell therapies, retinal diseases, and orphan neurodevelopmental disorders. Laura holds a BA in Biology and Psychology from Harvard University, and a PhD in Neuroscience from MIT. Her graduate research investigated synaptic translation in syndromic autism.

Agenda Sessions

  • Oncology: The in-rush of funds for IO and non-IO

    On Demand